These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28191636)

  • 21. Identification of genetic polymorphisms that predict responder/non-responder profiles to the RhD antigen.
    Tan JC; Armstrong NJ; Yuan FF; Flower RL; Dyer WB
    Mol Immunol; 2015 Dec; 68(2 Pt C):628-33. PubMed ID: 26505654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.
    Gudlaugsson B; Hjartardottir H; Svansdottir G; Gudmundsdottir G; Kjartansson S; Jonsson T; Gudmundsson S; Halldorsdottir AM
    Transfusion; 2020 Jan; 60(1):175-183. PubMed ID: 31850521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization.
    Körmöczi GF; Gassner C; Shao CP; Uchikawa M; Legler TJ
    Transfusion; 2005 Oct; 45(10):1561-7. PubMed ID: 16181205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two cases of the variant RHD*DAU5 allele associated with maternal alloanti-D.
    Duncan JA; Nahirniak S; Onell R; Clarke G
    Immunohematology; 2017 Jun; 33(2):60-63. PubMed ID: 28657764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RhD-Alloimmunization in Adult and Pediatric Trauma Patients.
    Gammon RR; Almozain N; Hermelin D; Klein N; Mangwana S; Nair AR; O'Brien JJ; Shmookler AD; Stephens L; Bocquet C
    Transfus Med Rev; 2024 Jul; 38(4):150842. PubMed ID: 39127022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.
    Karafin MS; Westlake M; Hauser RG; Tormey CA; Norris PJ; Roubinian NH; Wu Y; Triulzi DJ; Kleinman S; Hendrickson JE;
    Br J Haematol; 2018 Jun; 181(5):672-681. PubMed ID: 29675950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study).
    Schonewille H; Honohan Á; van der Watering LM; Hudig F; Te Boekhorst PA; Koopman-van Gemert AW; Brand A
    Transfusion; 2016 Feb; 56(2):311-20. PubMed ID: 26442648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of D alloimmunization in D- pediatric oncology patients receiving D-incompatible single-donor platelets.
    Molnar R; Johnson R; Sweat LT; Geiger TL
    Transfusion; 2002 Feb; 42(2):177-82. PubMed ID: 11896332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
    Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
    Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive protocols for transplantation and certain hematologic malignancies can prevent the primary immune response to the D blood group antigen.
    Seager A; Sandler SG
    Immunohematology; 2013; 29(3):110-4. PubMed ID: 24325172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-D Alloimmunization After RhD Positive Red Cell Transfusion to Selected RhD Negative Patients.
    Pandey P; Setya D; Singh MK
    Indian J Hematol Blood Transfus; 2022 Jul; 38(3):577-584. PubMed ID: 35747571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of Rh sensitization in the context of trauma: two case reports.
    Werch JB
    J Clin Apher; 2010; 25(2):70-3. PubMed ID: 20027640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does ABO and RhD matching matter for platelet transfusion?
    Dunbar NM
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):512-517. PubMed ID: 33275681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective surveillance of D- recipients of D+ apheresis platelets: alloimmunization against D is not detected.
    Weinstein R; Simard A; Ferschke J; Vauthrin M; Bailey JA; Greene M
    Transfusion; 2015 Jun; 55(6):1327-30. PubMed ID: 25523100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Red cell alloimmunization in RhD positive pregnant women and neonatal outcome.
    Sankaralingam P; Jain A; Bagga R; Kumar P; Marwaha N
    Transfus Apher Sci; 2016 Aug; 55(1):153-8. PubMed ID: 27324408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy.
    Koelewijn JM; Vrijkotte TG; de Haas M; van der Schoot CE; Bonsel GJ
    BJOG; 2009 Apr; 116(5):655-64. PubMed ID: 19210505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.
    Lin Y; Saskin A; Wells RA; Lenis M; Mamedov A; Callum J; Buckstein R
    Vox Sang; 2017 Jan; 112(1):79-86. PubMed ID: 28097704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Guideline for prevention of RhD alloimmunizationin RhD negative women].
    Lubušký M; Procházka M; Simetka O; Holusková I
    Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin.
    Nester TA; Rumsey DM; Howell CC; Gilligan DM; Drachman JG; Maier RV; Kyles DM; Matthews DC; Pendergrass TW
    Transfusion; 2004 Dec; 44(12):1720-3. PubMed ID: 15584986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receipt of older RBCs does not predispose D-negative recipients to anti-D alloimmunization.
    Yazer MH; Triulzi DJ
    Am J Clin Pathol; 2010 Sep; 134(3):443-7. PubMed ID: 20716801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.